Prospective Case Series Evaluating the Efficacy and Safety of NeoThelium FT for Venous Leg Ulcers

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorNuScience Medical Biologics, LLC

About this trial

This is a prospective case series evaluating the efficacy and safety of NeoThelium FT Amnion Skin Graft in the Mangement of Venous Leg Ulcers

Eligibility criteria

Qualifiers

Male or Female, 18 years of age or older

Subject has a medical diagnosis of venous leg ulcer or venous insufficiency with a lower extremity wound

Subject has an venous leg ulcer without infection or clinically visible exposed bone

Index wound is a minimum of 1 cm2 and a maximum of 30 cm2 at first treatment visit

Disqualifiers

Subject is unable to comply with protocol treatment

Presence of infection prior to screening.

Multiple VLUs on the same leg with < 2 cm separation from the target ulcer.

Subject has comorbid conditions that may compromise subject safety or wound healing in the opinion of the investigator, such as serious cardiovascular, renal, liver, pulmonary, autoimmune, palliative care, or inherited blood disorders

Trial design

Treatments tested in this trial

  • NeoThelium FT (HCT/P 361)

Treatment groups

10 Participants
are divided into 1 treatment group

Sponsors and collaborators